24 January 2006 in Advanced Functional Materials
23 November 2006 in Advanced Functional Materials
1 March 2010 in Chemistry – A European Journal
31 March 2014 in Chemical Communications
The dissociation of one pyridine of a pentadentate ligand (N4Py) from the Co centre was found to be responsible for the formation of a Co(III) hydride species, an indispensable intermediate for photocatalytic proton reduction.
2 June 2015 in Dalton Transactions
BODIPY (boron dipyrromethene) derivatives and Ru(II) complexes are two types of functional compounds that have found wide applications in the fields of biology and medicine. We herein synthesized two new Ru(II) arene complexes based on an iodized BODIPY-containing pyridine (py-I-BODIPY) ligand, [(p-cym)Ru(bpy)(py-I-BODIPY)]2+ (2) and [(p-cym)Ru(2-pydaT)(py-I-BODIPY)]2+ (3), where p-cym = para-cymene, bpy = 2,2′-bipyridine, and 2-pydaT = 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine. The photophysical, photochemical and photobiological properties of 2 and 3 were compared with that of [(p-cym)Ru(bpy)(py-BODIPY)]2+ (1). While 1 undergoes efficient monodentate ligand dissociation upon visible light irradiation and therefore may photobind DNA as a potential photoactivated chemotherapy (PACT) agent, 2 and 3 can generate 1O2 effectively and thus may serve as photosensitizers in photodynamic therapy (PDT). In electrophoresis experiments, 2 and 3 are even able to retard the mobility of plasmid DNA in the dark at high concentrations. More importantly, the cytotoxicities of 2 and 3 against human ovarian adenocarcinoma SKOV3 cells are enhanced about ten times under irradiation, leading to cytotoxicities more than one order of magnitude higher than that of cisplatin, demonstrating an efficient hybridization of the iodized BODIPY chromophore and the Ru(II) arene complex.
27 January 2017 in Inorganic Chemistry